Cite

HARVARD Citation

    Pang, X. et al. (2016). A combination therapy for KRAS‐mutant lung cancer by targeting synthetic lethal partners of mutant KRAS. Cancer communications. 35 (1), pp. 1-3. [Online]. 
  
Back to record